Foundation Healthcare Targets S$242 Million in Singapore IPO

Pricing and Structure

Foundation Healthcare Holdings has set its initial public offering at S$0.76 per share, aiming to raise S$242 million on the Singapore Exchange mainboard. The offering comprises 162.6 million shares split between an international placement of 153.4 million shares and a Singapore public tranche of 9.2 million shares.

The pricing values the company at approximately S$1 billion at listing. Ten cornerstone investors have committed roughly S$118 million, providing a strong anchor for the deal. The Singapore public offer opens July 1 at 9 pm and closes July 6 at noon, with trading scheduled to begin July 8 at 9 am.

OCBC and UBS Singapore serve as joint issue managers, while Jefferies Singapore, OCBC, UBS Singapore, DBS, and UOB act as joint bookrunners and underwriters.

Use of Proceeds

Foundation Healthcare plans to deploy the capital across three areas: acquiring specialist practices and medical centres in Singapore, supporting expansion into new geographies, and funding general corporate needs and working capital.

Liaw Yit Ming, chief executive officer of Foundation Healthcare, noted that the listing will provide resources to pursue strategic acquisitions, expand healthcare infrastructure and technology capabilities, and support the company's next growth phase. The group sees opportunity in what it describes as Singapore's fragmented private specialist healthcare market.

Financial Performance and Market Position

Foundation Healthcare reported revenue of S$265.9 million for fiscal year 2025, representing 32 percent year-on-year growth on a pro forma basis. Adjusted EBITDA reached S$99.1 million for the same period, up 33 percent year-on-year, also on a pro forma basis.

The company held a 7.2 percent share of Singapore's private specialist market by revenue in fiscal 2025. As of December 31, 2025, it employed 4.4 percent of Singapore's private medical specialists.

Business Model and Growth Strategy

Founded in 2023 with a S$150 million investment from SeaTown Private Capital Master Fund, Foundation Healthcare has built its platform by consolidating independent clinics across Singapore's specialist landscape. SeaTown is an investment manager owned indirectly by Temasek Holdings.

The consolidation strategy aims to create economies of scale and reduce administrative burdens for physicians. As of March 31, the group operates 108 medical specialists across 16 specialties, managing 74 specialist clinics and four medical centres. Its facilities include Foundation Ambulatory Centre locations in Novena and Orchard, Foundation Imaging for radiology services, and Care IVF for fertility treatment.

Regional Healthcare Dynamics

The offering arrives as private healthcare operators across Asia seek capital to scale operations amid rising demand for specialist-led care. Singapore's healthcare market features numerous independent practitioners, creating consolidation opportunities for platform operators with access to capital and operational infrastructure.

Liaw pointed to three long-term trends supporting the business: growing demand for specialist-led care, increasing appetite for affordable private healthcare, and a shift toward outpatient delivery models. These dynamics favor operators that can offer comprehensive specialist services under unified management while maintaining clinical quality.

The company's expansion plans beyond Singapore signal ambitions to replicate its consolidation model in other Southeast Asian markets, where fragmented specialist landscapes and growing middle-class populations present similar opportunities. Access to public market capital will enable Foundation Healthcare to move faster on acquisitions and infrastructure investments as it competes for assets across the region.

The listing adds another healthcare name to Singapore's exchange, reflecting sustained investor interest in the sector despite broader market volatility. Cornerstone backing at nearly half the total raise provides price stability and demonstrates institutional confidence in the company's growth trajectory.